- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Scott Hewitt Describes the Ongoing Shift to Value-Based Arrangements
While not every doctor is successful in value-based contracts, there is a shift in the right direction to more value-based care, explained Scott Hewitt, vice president, payment strategy and innovation, UnitedHealthcare.
While not every doctor is successful in value-based contracts, there is a shift in the right direction to more value-based care, explained Scott Hewitt, vice president, payment strategy and innovation, UnitedHealthcare.
Transcript
How have UnitedHealthcare’s value-based care contracts been improving?
So, we have a plethora of information or data points that we can look at, whether it’s reduced inpatient days, reduced [emergency room] use, increased [primary care physician] visits, lower specialty visits per 1000, but it’s more than just utilization metrics, it’s also quality metrics and when we look at quality metrics we’re seeing our providers are in a value-based contracting arrangement. So, it doesn’t necessarily need to be an [accountable care organization] but that they’re focused on and improving the care that members are receiving.
So, it might be lowering C-section rates, it might be focused on appropriate use of lab services, it might be prescription drug use or generic drug use, tier one drug use. There’s lots of different measures that we look at it at UnitedHealthcare and while not every provider is successful in these arrangements, if I look at my entire book of business, I am seeing the shift in the right direction.
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
